Latest debt-to-equity ratio

Artiva Biotherapeutics Debt-to-equity ratio

Direct answer

Artiva Biotherapeutics's debt-to-equity ratio is 2.83%.

The verified market snapshot reports 2.83%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.

Get free Artiva Biotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
2.83%